Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses

Immunogenic cell death (ICD) is a powerful trigger eliciting strong immune responses against tumors. However, traditional chemoimmunotherapy (CIT) does not last long enough to induce sufficient ICD, and also does not guarantee the safety of chemotherapeutics. To overcome the disadvantages of the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeongrae, Choi, Yongwhan, Yang, Suah, Lee, Jaewan, Choi, Jiwoong, Moon, Yujeong, Kim, Jinseong, Shim, Nayeon, Cho, Hanhee, Shim, Man Kyu, Jeon, Sangmin, Lim, Dong-Kwon, Yoon, Hong Yeol, Kim, Kwangmeyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954063/
https://www.ncbi.nlm.nih.gov/pubmed/35335852
http://dx.doi.org/10.3390/pharmaceutics14030474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954063/
https://www.ncbi.nlm.nih.gov/pubmed/35335852
http://dx.doi.org/10.3390/pharmaceutics14030474

Ejemplares similares